Showing results (1051-1060 of 1,275) with videos related to

Sort By:
Pageof 128
Veterinary and Comparative Oncology|December 19, 2024
Immunohistochemical Expression of Programmed Death-Ligand 1 and Cytotoxic T-Lymphocyte Antigen-4 in Canine Cutaneous Mast Cell TumoursMariana Pinto Ribeiro, Ana Canadas-Sousa, Catarina Aluai-Cunha, et al.
Veterinary and Comparative Oncology|December 4, 2024
Do Pre-Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?Valerie J Poirier, Valeria Meier, Michelle Turek, et al.
Veterinary and Comparative Oncology|November 11, 2024
Immunological Pre-Metastatic Niche in Dogs With Naturally Occurring OsteosarcomaMikael Kerboeuf, Kristin Paaske Anfinsen, Erling Olaf Koppang, et al.
Veterinary and Comparative Oncology|September 25, 2024
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma CellsKosuke Kobayashi, Kohei Murakami, Kenji Baba
Veterinary and Comparative Oncology|September 23, 2024
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary CarcinomasClarissa C Freemyer, Tracy L Gieger, Shelly L Vaden, et al.
Veterinary and Comparative Oncology|October 18, 2024
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell TumourGiulia Iamone, Carmit Chalfon, Laura Marconato, et al.
Veterinary and Comparative Oncology|February 10, 2025
The Outcomes and Surgical Complications of Cats With Oral Squamous Cell Carcinoma Treated With Total Glosso-Mandibulectomy: 20 Cases (2008-2022)Taisuke Iwata, Masanao Ichimata, Atsushi Fujita, et al.
Veterinary and Comparative Oncology|August 20, 2024
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding PharmaciesSamantha R Bajorek, Trina N Hazzah, John D Chretin, et al.
Veterinary and Comparative Oncology|August 20, 2024
Macrophage Colony Stimulating Factor (M-CSF) and Interleukin-34 (IL-34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune MicroenvironmentChristopher J Robinson, Cambri E Moeller, Cally N Quick, et al.
Pageof 128